Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
12.2%
% of AGNG's 82 holdings also in HRTS
25.6%
% of HRTS's 39 holdings also in AGNG
Overlap by Weight
Sector Drift (AGNG minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.9% | 3.9% | 3.9% |
 |
BOSTON SCIENTIFIC CORP | 3.6% | 3.1% | 3.1% |
|
AMGEN INC | 3.0% | 5.1% | 3.0% |
 |
MEDTRONIC PLC | 3.0% | 3.0% | 3.0% |
|
ELI LILLY & CO | 2.8% | 6.4% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
AGNG Overweight Relative to HRTS
|
WELLTOWER, INC. | 4.3% |
|
BRISTOL-MYERS SQUIBB CO | 3.3% |
|
STRYKER CORP | 3.2% |
 |
UCB SA | 3.0% |
|
JOHNSON & JOHNSON | 3.0% |
 |
ALCON, INC. | 2.9% |
|
ABBVIE INC | 2.8% |
|
ROCHE HOLDING AG-BR | 2.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.6% |
|
TERUMO CORP | 2.5% |
AGNG Underweight Relative to HRTS
|
VERTEX PHARMACEUTICALS INC | -5.7% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
|
ELI LILLY & CO | -3.6% |
|
CYTOKINETICS INC | -3.3% |
|
ASTRAZENECA PLC | -3.1% |
|
ASCENDIS PHARMA A/S | -3.1% |
|
MIRUM PHARMACEUTICALS, INC. | -2.6% |
|
MASIMO CORPORATION | -2.5% |